New malaria pill shows promise in clearing parasites fast
NCT ID NCT07235020
First seen Nov 19, 2025 · Last updated May 12, 2026 · Updated 30 times
Summary
This study tested a new anti-malarial drug called INE963 in 52 adults with uncomplicated P. falciparum malaria. The main goal was to see how quickly the drug clears malaria parasites from the blood. Researchers also checked the 28-day cure rate and drug safety. The study was completed and provides early data on this potential new treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for UNCOMPLICATED PLASMODIUM FALCIPARUM MALARIA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Novartis Investigative Site
Banfora, Burkina Faso
-
Novartis Investigative Site
Azaguié, BP 173, Côte d’Ivoire
-
Novartis Investigative Site
Lambaréné, BP 242, Gabon
-
Novartis Investigative Site
Navrongo, VWJ6+8WF, Ghana
-
Novartis Investigative Site
Kisumu, 40100, Kenya
-
Novartis Investigative Site
Kampala, Uganda
Conditions
Explore the condition pages connected to this study.